Correlation Between Vincerx Pharma and Fortress Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Fortress Biotech, you can compare the effects of market volatilities on Vincerx Pharma and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Fortress Biotech.

Diversification Opportunities for Vincerx Pharma and Fortress Biotech

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vincerx and Fortress is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Fortress Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Fortress Biotech go up and down completely randomly.

Pair Corralation between Vincerx Pharma and Fortress Biotech

Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the Fortress Biotech. In addition to that, Vincerx Pharma is 1.12 times more volatile than Fortress Biotech. It trades about -0.13 of its total potential returns per unit of risk. Fortress Biotech is currently generating about 0.05 per unit of volatility. If you would invest  168.00  in Fortress Biotech on September 24, 2024 and sell it today you would earn a total of  4.00  from holding Fortress Biotech or generate 2.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vincerx Pharma  vs.  Fortress Biotech

 Performance 
       Timeline  
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Fortress Biotech 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Fortress Biotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, Fortress Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Vincerx Pharma and Fortress Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vincerx Pharma and Fortress Biotech

The main advantage of trading using opposite Vincerx Pharma and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.
The idea behind Vincerx Pharma and Fortress Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios